Book description
This book comprehensively covers the mechanisms of action and inhibitor
design for HIV-1 integrase. It serves as a resource for scientists
facing challenging drug design issues and researchers in antiviral drug
discovery. Despite numerous review articles and isolated book chapters
dealing with HIV-1 integrase, there has not been a single source for
those working to devise anti-AIDS drugs against this promising target.
But this book fills that gap and offers a valuable introduction to the
field for the interdisciplinary scientists who will need to work
together to design drugs that target HIV-1 integrase.
Nouri Neamati, PhD, is an Associate Professor of Pharmacology and
Pharmaceutical Sciences at the University of Southern California
School of Pharmacy. He is the recipient of numerous awards and has
published more than 170 peer-reviewed manuscripts, several book
chapters, and patents in the area of drug design and discovery. Dr.
Neamati is the Editor-in-Chief of Current Molecular Pharmacology; an
Associate Editor of Current Cancer Drug Targets; and an Editorial
Advisory Board member of several journals including Expert Opinion on
Drug Discovery, Expert Opinion on Investigational Drugs, and Hormones
& Cancer.
